Stryker sued again over allegedly faulty metal hip implant

Another patient is suing Stryker ($STK) over an allegedly faulty metal hip implant. This time, a Kentucky man is seeking compensation.

Injury Lawyer News reports that the man filed the lawsuit in a U.S. District Court in Kentucky at the end of June over the company's Rejuvenate hip implant. He received a left hip replacement in July 2010, the story notes, but experienced pain and discomfort in the months that followed, and the hip failed. Despite a second surgery to replace it in January, the patient claims he remains damaged and in pain, and his medical, pharmaceutical and rehab bills have climbed as he's gone through follow-up care.

The patient is seeking actual and punitive damages, according to the article. And now his lawsuit gets added to the many others Stryker is now facing, along with many other metal hip manufacturers. Just last month, an Illinois man sued Stryker for $100 million, alleging a faulty ABG II hip replacement--that lawsuit alleges that Stryker knew the risk and didn't adequately warn patients. The Illinois man also claims he suffered everything from soft tissue damage to metal poisoning, the need for additional surgeries and massive pain.

Stryker's orthopedic division voluntarily recalled its ABG II and Rejuvenate hips in July 2012. The company has said its bottom line is taking a hit from the escalating cost of its all-metal hip recalls. Stryker execs previously noted that they expect to pay as much as $390 million to cover total recall costs.

- read the full story

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.